Annual Current Liabilities
$2.38 M
+$1.18 M+99.33%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual total current liabilities is $2.38 million, with the most recent change of +$1.18 million (+99.33%) on December 31, 2023.
- During the last 3 years, AMPE annual current liabilities has risen by +$542.00 thousand (+29.55%).
- AMPE annual current liabilities is now -56.92% below its all-time high of $5.52 million, reached on December 31, 2015.
Performance
AMPE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.38 M
+$105.00 K+4.62%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly total current liabilities is $2.38 million, with the most recent change of +$105.00 thousand (+4.62%) on December 31, 2023.
- Over the past year, AMPE quarterly current liabilities has increased by +$1.18 million (+99.33%).
- AMPE quarterly current liabilities is now -57.00% below its all-time high of $5.53 million, reached on March 31, 2022.
Performance
AMPE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AMPE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.3% | +99.3% |
| 3 y3 years | +29.6% | +29.6% |
| 5 y5 years | +71.7% | +71.7% |
AMPE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.6% | +99.3% | -57.0% | +99.3% |
| 5 y | 5-year | -53.6% | +99.3% | -57.0% | +99.3% |
| alltime | all time | -56.9% | >+9999.0% | -57.0% | >+9999.0% |
Ampio Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.38 M(+99.3%) | $2.38 M(+4.6%) |
| Sep 2023 | - | $2.27 M(-9.0%) |
| Jun 2023 | - | $2.50 M(-6.6%) |
| Mar 2023 | - | $2.67 M(+124.2%) |
| Dec 2022 | $1.19 M(-76.7%) | $1.19 M(-69.6%) |
| Sep 2022 | - | $3.92 M(-22.8%) |
| Jun 2022 | - | $5.08 M(-8.0%) |
| Mar 2022 | - | $5.53 M(+7.9%) |
| Dec 2021 | $5.12 M(+179.3%) | $5.12 M(+114.6%) |
| Sep 2021 | - | $2.39 M(-26.2%) |
| Jun 2021 | - | $3.23 M(+97.0%) |
| Mar 2021 | - | $1.64 M(-10.5%) |
| Dec 2020 | $1.83 M(-57.2%) | $1.83 M(-4.4%) |
| Sep 2020 | - | $1.92 M(-24.4%) |
| Jun 2020 | - | $2.54 M(-43.3%) |
| Mar 2020 | - | $4.48 M(+4.6%) |
| Dec 2019 | $4.28 M(+209.5%) | $4.28 M(+79.8%) |
| Sep 2019 | - | $2.38 M(+2.5%) |
| Jun 2019 | - | $2.32 M(+48.9%) |
| Mar 2019 | - | $1.56 M(+12.8%) |
| Dec 2018 | $1.38 M(-64.3%) | $1.38 M(-19.7%) |
| Sep 2018 | - | $1.72 M(-46.5%) |
| Jun 2018 | - | $3.22 M(-8.9%) |
| Mar 2018 | - | $3.54 M(-8.9%) |
| Dec 2017 | $3.88 M(+81.7%) | $3.88 M(+70.7%) |
| Sep 2017 | - | $2.27 M(-27.9%) |
| Jun 2017 | - | $3.15 M(+47.9%) |
| Mar 2017 | - | $2.13 M(-0.3%) |
| Dec 2016 | $2.13 M(-61.3%) | $2.13 M(-11.5%) |
| Sep 2016 | - | $2.41 M(-7.6%) |
| Jun 2016 | - | $2.61 M(-21.1%) |
| Mar 2016 | - | $3.31 M(-40.0%) |
| Dec 2015 | $5.52 M | $5.52 M(+41.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $3.90 M(+10.2%) |
| Jun 2015 | - | $3.54 M(+60.4%) |
| Mar 2015 | - | $2.20 M(-40.1%) |
| Dec 2014 | $3.68 M(+48.8%) | $3.68 M(+17.3%) |
| Sep 2014 | - | $3.14 M(-26.9%) |
| Jun 2014 | - | $4.29 M(-15.4%) |
| Mar 2014 | - | $5.07 M(+105.1%) |
| Dec 2013 | $2.47 M(+51.1%) | $2.47 M(+18.6%) |
| Sep 2013 | - | $2.09 M(-14.2%) |
| Jun 2013 | - | $2.43 M(+41.1%) |
| Mar 2013 | - | $1.72 M(+5.3%) |
| Dec 2012 | $1.64 M(+26.7%) | $1.64 M(+26.1%) |
| Sep 2012 | - | $1.30 M(+18.4%) |
| Jun 2012 | - | $1.10 M(+20.3%) |
| Mar 2012 | - | $910.40 K(-29.5%) |
| Dec 2011 | $1.29 M(-72.8%) | $1.29 M(-23.7%) |
| Sep 2011 | - | $1.69 M(-28.9%) |
| Jun 2011 | - | $2.38 M(+18.2%) |
| Mar 2011 | - | $2.01 M(-57.6%) |
| Dec 2010 | $4.75 M(+1239.5%) | $4.75 M(+192.2%) |
| Sep 2010 | - | $1.62 M(+69.0%) |
| Jun 2010 | - | $961.20 K(+76.9%) |
| Mar 2010 | - | $543.40 K(+53.4%) |
| Dec 2009 | $354.30 K(+361.3%) | $354.30 K(+274.9%) |
| Sep 2009 | - | $94.50 K(+4.5%) |
| Jun 2009 | - | $90.40 K(+3.9%) |
| Mar 2009 | - | $87.00 K(+13.3%) |
| Dec 2008 | $76.80 K(+75.7%) | $76.80 K(+10.2%) |
| Sep 2008 | - | $69.70 K(+4.8%) |
| Jun 2008 | - | $66.50 K(+11.6%) |
| Mar 2008 | - | $59.60 K(+36.4%) |
| Dec 2007 | $43.70 K(+332.7%) | $43.70 K(+2.3%) |
| Sep 2007 | - | $42.70 K(+322.8%) |
| Dec 2006 | $10.10 K | $10.10 K |
FAQ
- What is Ampio Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual current liabilities year-on-year change?
- What is Ampio Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly current liabilities year-on-year change?
What is Ampio Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AMPE is $2.38 M
What is the all time high annual current liabilities for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual total current liabilities is $5.52 M
What is Ampio Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AMPE annual total current liabilities has changed by +$1.18 M (+99.33%)
What is Ampio Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AMPE is $2.38 M
What is the all time high quarterly current liabilities for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly total current liabilities is $5.53 M
What is Ampio Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AMPE quarterly total current liabilities has changed by +$1.18 M (+99.33%)